Lumos Pharma Inc.

(LUMO) Trade

By |

Profile

Lumos Pharma is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operates primarily in the United States.

Contact Information

Website: www.lumos-pharma.com
Email: ir@lumos-pharma.com
Main Phone: +1 512 215-2630
Address: 4200 Marathon Boulevard
Address 2: Suite 200
State: TX
City / Town: Austin
Country: US
Postal Code: 78756

Issuer Information

Exchange: NSD
CEO: Richard J. Hawkins
Employees: 28
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Lumos Pharma is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operates primarily in the United States.

Contact Information

Website: www.lumos-pharma.com
Email: ir@lumos-pharma.com
Main Phone: +1 512 215-2630
Address: 4200 Marathon Boulevard
Address 2: Suite 200
State: TX
City / Town: Austin
Country: US
Postal Code: 78756

Issuer Information

Exchange: NSD
CEO: Richard J. Hawkins
Employees: 28
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 15.38 $ -0.13 (-0.84%)
Last Price 15.38 Change $ -0.13 Change % -0.84 Tick N/A
Bid 15.63 Bid Size 3.00 Ask 16.15 Ask Size 1.00
Open 15.57 High 15.69 Low 15.07 Prev Close 15.51
Last Trade Volume 6,721 52 Wk Hi 32.41 52 Wk Low 6.75
Market Cap 127.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 8,297,058.00 EPS (TTM) -3.69 PE Ratio -4.10 Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 3 5
Number of Buys 1 1
Number of Sells 2 4
Net Activity 1443 1008
Last 10 Buys Shares
Ernest J. Talarico 1,000
John B. Henneman 1,000
John B. Henneman 1,000
Charles J. Link 1,000
David J. Lundquist 1,000
Last 10 Sell Shares
Ernest J. Talarico 1,000
Carl W. Langren 1,000
Carl W. Langren 1,000
Charles J. Link 1,000
Charles J. Link 1,000
Charles J. Link 1,000
Charles J. Link 1,000
Charles J. Link 1,000
Charles J. Link 1,000
Charles J. Link 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 4 4 4 4
Low Target Price Estimate 4 4 4 4
Mean Target Price Estimate 4 4 4 4
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 11/06/19 11/06/19 11/06/19 11/06/19
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 3 3 3 3